SIMCERE PHARMA News

Xiansheng Pharmaceutical (02096.HK): Strong trend of innovation and improvement, optimistic about profit improvement

浙商證券Apr 19 16:16

Xiansheng Pharmaceutical (02096.HK): Innovative drug revenue share increased, looking forward to more new drugs being launched

廣發證券Mar 25 00:00

CICC: Maintaining Xiansheng Pharmaceutical's (02096) “Outperform the Industry” rating target price of HK$7.7

Zhitong FinanceMar 22 09:55

Xiansheng Pharmaceutical (02096.HK): 2023 core profit meets expectations, innovation is expected to drive growth

中金公司Mar 22 07:16

Xiansheng Pharmaceutical (2096.HK): Recovery is imminent and products are being implemented intensively

西南證券Mar 22 00:00

Xiansheng Pharmaceutical (2096.HK): Performance fluctuations are gradually being cleared, and high growth can be expected in 2024, when the lightweight market is up

交銀國際Mar 21 00:00

Xiansheng Pharmaceutical (2096.HK): Performance growth in 2023 will be dragged down by external disturbances, and high growth will resume in 2024 and can still be expected to maintain purchases

交銀國際Feb 20 07:32

Xiansheng Pharmaceutical (2096.HK): Bank of China Bank International's 2023 Medical Industry Enterprise Daily Report

交銀國際Nov 24, 2023 00:00

Xiansheng Pharmaceutical (02096.HK): Performance is growing rapidly, and the share of innovative drugs continues to rise

中信證券Aug 29, 2023 00:00

Xiansheng Pharmaceutical (2096.HK): Innovative drugs account for a high share of revenue and smooth commercial expansion

財通證券Aug 28, 2023 00:00

Xiansheng Pharmaceutical (02096.HK): Revenue is growing steadily and the share of innovation continues to rise

廣發證券Aug 25, 2023 00:00

Xiansheng Pharmaceutical (2096.HK): Strong revenue performance and continuous increase in the share of innovation

華泰證券Aug 23, 2023 14:56

SIMCERE PHARMACEUTICAL(2096.HK):INNOVATIVE DRUGS CONTRIBUTING MAJORITY OF SALES

招银国际Aug 23, 2023 10:22

Xiansheng Pharmaceutical (02096.HK): 1H23 meets expectations, innovation pipeline continues to yield

中金公司Aug 23, 2023 07:56

Xiansheng Pharmaceutical (2096.HK): Performance is in line with expectations, long-term growth momentum is strong

西南證券Aug 22, 2023 00:00

Xiansheng Pharmaceutical (02096.HK): Innovate, improve, and be optimistic about delivery

浙商證券Aug 22, 2023 00:00

Xiansheng Pharmaceutical (02096.HK): Underrated Differentiated High Growth BIOPHARMA

浙商證券Apr 14, 2023 00:00

Xiansheng Pharmaceutical (02096.HK): Sales continue to grow and differentiated pipelines are gradually being enriched

興業證券Apr 10, 2023 14:41

Xiansheng Pharmaceutical (02096.HK): Performance continues to rise, and the share of innovation has broken through a new high

廣發證券Apr 6, 2023 17:12

Xiansheng Pharmaceutical (02096.HK): 2022 performance is in line with expectations and the innovation pipeline continues to advance

中金公司Apr 4, 2023 13:36